Entero Therapeutics, Inc. (ENTO)
NASDAQ: ENTO · Real-Time Price · USD
0.3790
-0.0560 (-12.87%)
At close: Jun 27, 2025, 4:00 PM
0.3620
-0.0170 (-4.49%)
After-hours: Jun 27, 2025, 7:42 PM EDT
Entero Therapeutics Market Cap
Entero Therapeutics has a market cap or net worth of $1.81 million as of June 27, 2025. Its market cap has decreased by -69.39% in one year.
Market Cap
1.81M
Enterprise Value
2.58M
1-Year Change
-69.39%
Ranking
Category
Stock Price
0.38
Market Cap Chart
Since October 11, 2016, Entero Therapeutics's market cap has decreased from $49.20M to $1.81M, a decrease of -96.33%. That is a compound annual growth rate of -31.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 2.10M | -30.00% |
| Dec 31, 2024 | 3.00M | 7.14% |
| Dec 29, 2023 | 2.80M | -45.10% |
| Dec 30, 2022 | 5.10M | -71.67% |
| Dec 31, 2021 | 18.00M | -38.98% |
| Dec 31, 2020 | 29.50M | 8.46% |
| Dec 31, 2019 | 27.20M | 32.68% |
| Dec 31, 2018 | 20.50M | -51.19% |
| Dec 29, 2017 | 42.00M | -7.89% |
| Dec 30, 2016 | 45.60M | -7.32% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 705.58B |
| Johnson & Johnson | 367.53B |
| AbbVie | 329.36B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 279.54B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 233.19B |
| AstraZeneca | 215.99B |